Monograph Title | Section | Source Publication | Page Number | Errata Post Date | Errata Official Date | Target Errata Print Publication Sort descending | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
PROMETHAZINE HYDROCHLORIDE | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | Change System suitability solution: 5 µg/mL each of USP Promethazine Hydrochloride RS and USP Promethazine Related Compound B RS from the Standard stock solution and System suitability stock solution, respectively Standard… Read More |
METARAMINOL BITARTRATE | SPECIFIC TESTS/Content of Tartaric Acid | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Analysis: Change Result = {[(VS−VB) × N × F]/2 × W} × 100 to: Result = {[(VS−VB) × N × F]/(2 × W)} × 100 |
REAGENTS AND REFERENCE TABLES | Reagent Specifications/Tosylchloramide Sodium | USPNF Online | Online | 28-Jul-2023 | 1-Aug-2023 | NA | NA | Change 127-65-1 to: 7080-50-4 |
SECOBARBITAL SODIUM | OTHER REQUIREMENTS | USPNF Online | Online | 29-Dec-2023 | 1-Jan-2024 | NA | NA | Change Where the label states that Seco barbital Sodium is sterile, it meets the requirements for Sterility Tests 〈71〉 and for Bacterial endotoxins under Secobarbital Sodium for Injection. Where the label states that Secobarbital Sodium… Read More |
DOXYCYCLINE FOR INJECTION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
NALOXONE HYDROCHLORIDE | IMPURITIES | USPNF Online | Online | 28-Oct-2022 | 1-Dec-2022 | NA | NA | In Limit of Naloxone Related Compound D: Delete Sensitivity solution: 1.25 µg/mL of USP Naloxone Related Compound D RS in 0.1 N hydrochloric acid AND In System suitability/Samples: Delete Sensitivity solution,… Read More |
ISOFLURANE | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Analysis: Change Result = (rU/rS) × CS × (1/F) to: Result = (rU/rS) × CF × (1/F) AND Change CS… Read More |
DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 29-Sep-2023 | 1-Oct-2023 | NA | NA | In Dissolution 〈711〉/Test 8/Tolerances: Change The percentage of the labeled amount of valproic acid (C8H16O2) dissolved at the times specified conform to Dissolution <711>, Acceptance… Read More |
LANSOPRAZOLE DELAYED-RELEASE CAPSULES | IMPURITIES/Organic Impurities | USPNF Online | Online | 30-Sep-2022 | 1-Oct-2022 | NA | NA | Delete Blank: Methanol and Diluent (1:9) |
ERYTHROMYCIN DELAYED-RELEASE TABLETS | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Test 1: Change Buffer stage Medium: 0.05 M pH 6.8 phosphate buffer (see Reagents, Indicators, and Solutions—Buffer Solutions) to: Buffer stage Medium: 0.05 M pH 6.8 phosphate buffer (see Reagents,… Read More |
DEXTROMETHORPHAN HYDROBROMIDE ORAL SOLUTION | Assay | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Chromatographic system and Procedure: Change C is the concentration, in mg per mL, of USP Dextromethorphan Hydrobromide RS, on the anhydrous basis, in the Standard preparation; to: C is the concentration, in mg per mL… Read More |
METOLAZONE | IMPURITIES | USPNF Online | Online | 23-Feb-2024 | 1-Mar-2024 | NA | NA | In Organic Impurities/Chromatographic system/Column: Change 4.6-mm × 25-cm; 5-µm packing 1 to: 4.6-mm × 25-cm; 5-µm packing L1 |
AMMONIUM GLYCYRRHIZATE | ASSAY/Content of Ammonium 18α- and 18β-Glycyrrhizate | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In Analysis: Change MW(Salt) = molecular weight of ammonium glycyrrhizate, 840.08 g/mol MW(Acid) = molecular weight of glycyrrhizic acid, 821.59 g/mol to: MW(Salt) = molecular weight of… Read More |
MAFENIDE ACETATE FOR TOPICAL SOLUTION | IMPURITIES/Organic Impurities | USPNF Online | Online | 16-Dec-2022 | 1-Jan-2023 | NA | NA | In System suitability: Change Samples: System suitability solution, Standard solution A, and Standard solution B to: Samples: System suitability solution and Standard solution A AND … Read More |
OSELTAMIVIR PHOSPHATE | IMPURITIES/Organic Impurities/Procedure 3: Limit Of Tributyl Phosphine Oxide | USPNF Online | Online | 26-May-2023 | 1-Jun-2023 | NA | NA | In System suitability/Suitability requirements/Relative standard deviation: Change NMT 10.0% for the tributyl phosphine oxide and osteltamivir phosphate peaks to: NMT 10.0% for the tributyl phosphine oxide and oseltamivir phosphate… Read More |
<631> COLOR AND ACHROMICITY | METHOD II: INSTRUMENTAL (QUANTITATIVE) ASSESSMENT OF COLOR AND COLOR MATCHES | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Table 5: Change Sum 98.809 100.000 107.307 White point 98.811 100.000 107.304 to: Sum 94.809 100.000 107.307 White point 94.811 100.000 107.304 |
<565> BOTANICAL EXTRACTS | PREPARATIONS | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In General Pharmacopeial Requirements/Pesticide Residues: Change where L is the limit in the original article as listed in Table 4 (see Pesticide Residue Analysis under Articles of Botanical Origin <561>)… Read More |
DOXORUBICIN HYDROCHLORIDE FOR INJECTION | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
LEVORPHANOL TARTRATE TABLETS | PERFORMANCE TESTS/Uniformity of Dosage Units 〈905〉 | USPNF Online | Online | 31-Mar-2023 | 1-Aug-2023 | NA | NA | In Sample solution: Change Nominally about 80 ug/mL of levorphanol tartrate in Diluent prepared as follows. to: Nominally about 80 µg/mL of levorphanol tartrate in Diluent prepared as follows. |
OCTOCRYLENE | IDENTIFICATION | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In A./Acceptance criteria: Change NMT 3.0%, calculated on the as-is basis to: Absorptivities, calculated on the as-is basis, do not differ by more than 3.0%. |
BROMPHENIRAMINE MALEATE | SPECIFIC TESTS | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | Change Optical Rotation 〈781〉 to: Optical Rotation, Angular Rotation 〈781A〉 |
POWDERED FORSKOHLII EXTRACT | COMPOSITION/Content of Forskolin | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | In Chromatographic system: Change Column: 4.6-mm × 25-cm; 5-µm, 100 Å to: Column: 4.6-mm × 25-cm; 5-µm, 100 Å; packing L1 |
MESO-ZEAXANTHIN | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | In USP meso-Zeaxanthin RS: Change (3R,3′S-meso)-Zeaxanthin. to: (3R,3′S)-Zeaxanthin. |
ATORVASTATIN CALCIUM TABLETS | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In Test 1, Test 3, Test 4, Test 5, and Test 6/Analysis: Change Mr1 = molecular weight of atorvastatin, 558.64 Mr2 = molecular weight of atorvastatin calcium, 1155.34 to: … Read More |
PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Dissolution 〈711〉/Test 2/Acid stage: Change Acid stage standard solution: (L/10) mg/mL of USP Pantoprazole Sodium RS from the Standard stock solution in Acid stage medium, where L is the label claim… Read More |
PROMETHAZINE HYDROCHLORIDE TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | Change System suitability solution: 5 µg/mL each of USP Promethazine Hydrochloride RS and USP Promethazine Related Compound B RS from the Standard stock solution and System suitability stock solution, respectively Standard… Read More |
METARAMINOL BITARTRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In USP Metaraminol Enantiomer RS: Change 3-[(1S,2R)-2-Amino-1-hydroxypropyl]phenol. C9H13NO2 167.21 to: 3-[(1S,2R)-2-Amino-1-hydroxypropyl]phenol D-tartrate. C9H… Read More |
TRIAZOLAM TABLETS | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 28-Jul-2023 | 1-Aug-2023 | NA | NA | In Standard solution: Change Tablet/mg to: mg/Tablet |
AMOXICILLIN ORAL SUSPENSION | IDENTIFICATION | USPNF Online | Online | 26-Jan-2024 | 1-Feb-2024 | NA | NA | Change Shake a portion of Oral Suspension with a mixture of acetone and 0.1 N hydrochloric acid (4:1) to obtain a solution containing about 1 mg of amoxicillin per mL. The solution responds to the Identification test under Amoxicillin Capsules.… Read More |
DOXYCYCLINE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
FELODIPINE | IMPURITIES/Organic Impurities | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | Change Buffer, Mobile phase, System suitability solution, Standard solution, Sample solution, and Chromatographic system: Proceed as directed in the Assay. to: Buffer, Mobile phase… Read More |
BUPIVACAINE HYDROCHLORIDE INJECTION | ASSAY/Procedure | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Chromatographic system/Column: Change 4-mm × 30-cm; packing L1 to: 3.9-mm × 30-cm; packing L1 AND In System suitability: Change [Note—The relative retention times for bupivacaine hydrochloride and dibutyl phthalate are… Read More |
TAMSULOSIN HYDROCHLORIDE CAPSULES | IMPURITIES | USPNF Online | Online | 29-Sep-2023 | 1-Oct-2023 | NA | NA | In Organic Impurities/System suitability: Change Sample: Standard solution [Note—The relative retention times for methoxy tamsulosin, tamsulosin, ethoxyphenoxy ethyl bromide, and desethoxy tamsulosin are 0.73, 1.00, 1.80… Read More |
<659> PACKAGING AND STORAGE REQUIREMENTS | GENERAL DEFINITIONS/Packaging Definitions | Second Supplement to USP43–NF38 | Online | 26-Mar-2021 | 1-Dec-2025 | NA | NA | In Light-resistant container: Change 〈661.2〉, Functionality, Spectral Transmission Requirements for Light-Resistant Components and Systems. to: 〈661.2〉, Functionality Test Method, Spectral Transmission Requirements for Light-… Read More |
CEFTIOFUR HYDROCHLORIDE | ASSAY/Procedure | USPNF Online | Online | 30-Sep-2022 | 1-Oct-2022 | NA | NA | In Analysis: Change Calculate the percentage of ceftiofur (C19H17N5O7S3) in the portion of Ceftiofur Hydrochloride taken: Result = (rU/rS… Read More |
ERYTHROMYCIN ETHYLSUCCINATE FOR ORAL SUSPENSION | Identification | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | Change Proceed as directed in the Identification test under Erythromycin Ethylsuccinate Oral Suspension, beginning with “Prepare a Standard solution.” to: Prepare a Standard solution of USP Erythromycin Ethylsuccinate RS in methanol… Read More |
AMANTADINE HYDROCHLORIDE | IDENTIFICATION | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In A.: Change Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197A, 197K, and 197S to: Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197A, 197K, or 197S Procedure for… Read More |
PROPOFOL | ASSAY | USPNF Online | Online | 23-Feb-2024 | 1-Mar-2024 | NA | NA | In Procedure 2/Mobile phase: Change Hexane, acetonitrile, and alcohol (990: 7.5: 1) to: Hexane, acetonitrile, and alcohol, absolute (990: 7.5: 1) |
AMMONIUM GLYCYRRHIZATE | SPECIFIC TESTS | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In Optical Rotation, Specific Rotation 〈781〉: Change 〈781〉 to: 〈781S〉 AND Change Acceptance criteria: +49.0 to +55.0 on the anhydrous basis to: Acceptance criteria: +49.0° to +55.0° on the anhydrous basis |
PALONOSETRON HYDROCHLORIDE | IMPURITIES | USPNF Online | Online | 16-Dec-2022 | 1-Jan-2023 | NA | NA | In Limit of Unspecified Impurities: Change Mobile phase and Chromatographic system: Proceed as directed in the Assay. to: Mobile phase, Standard stock solution, and Chromatographic system: Proceed… Read More |
CALCIUM ASCORBATE | IDENTIFICATION/A. | USPNF Online | Online | 26-May-2023 | 1-Aug-2023 | NA | NA | Change Characteristic emission lines for calcium at 184.0, 315.9, and 317.9 nm from the Sample solution correspond to those from the Standard solution, as obtained in the Assay. to: Characteristic emission lines for calcium at 184.0,… Read More |
<915> MEASUREMENT OF STRUCTURAL STRENGTH OF SEMISOLIDS BY PENETROMETRY | APPARATUS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Figure 2: Change 66±0.25 Ø to: 65±0.25 Ø |
SODIUM SALICYLATE | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉: Add USP Phenol RS |
NANDROLONE DECANOATE | ASSAY/Procedure | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In Analysis: Change Calculate the percentage of Nandrolone Decanoate (C28H44O3) in the portion of Nandrolone Decanoate taken: to: Calculate the percentage of nandrolone decanoate (C28H44O… Read More |
DOXORUBICIN HYDROCHLORIDE INJECTION | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Test 2/Analysis: Change CS = concentration of USP Norethindrone Acetate RS (mg/mL) or USP Ethinyl Estradiol RS (ug/mL) in the Standard solution to: CS = concentration of USP Norethindrone Acetate… Read More |
ZIPRASIDONE CAPSULES | ASSAY | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Procedure/Analysis: Change 449.40 to: 449.39 |
DAPSONE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In Dissolution 〈711〉/Standard solution: Change USP Dapsone RS of a known concentration in Medium to: (L/1000) mg/mL of USP Dapsone RS in Medium, where L is the label claim in mg/Tablet. Transfer a portion of this… Read More |
FORSKOHLII | COMPOSITION/Content of Forskolin | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | In Chromatographic system: Change Column: 4.6-mm × 25-cm; 5-µm, 100 Å to: Column: 4.6-mm × 25-cm; 5-µm, 100 Å; packing L1 |
AZTEC MARIGOLD ZEAXANTHIN EXTRACT | IDENTIFICATION/C. | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | Change (3R,3′S meso)-zeaxanthin to: (3R,3′S)-zeaxanthin |